| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 39.66M | — |
| Operating expense | — | — |
| Net income | 8.75M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ZVRA returned +23.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +30.0% |
| 1 year | +23.4% |
| 5 years | +25.3% |
| 10 years | -83.1% |
| All-time high | $317.76 (Dec 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ZVRA would be worth today ›No. Zevra Therapeutics, Inc. has not paid a dividend in the past 12 months.
Zevra Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol ZVRA.
Zevra Therapeutics, Inc. is part of the Healthcare sector.
Zevra Therapeutics, Inc. has a market cap of 691.82M USD, based on the latest quote.
Zevra Therapeutics, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
